Procoagulant activity of human neuroblastoma cell lines, in relation to cell growth, differentiation and cytogenetic abnormalities

Japanese Journal of Cancer Research : Gann
N EsumiY Fujisawa

Abstract

Procoagulant activity (PCA) was investigated in relation to cell growth, differentiation, and cytogenetics in seven human neuroblastoma cell lines. Before 5-bromodeoxyuridine (BrdUrd) treatment, PCA was notably heterogeneous, with the highest activity in NCG (S-type in morphology) 40- to 100-fold greater than the lowest activity in SK-N-DZ (N-type). PCA was not related to 1p abnormalities. After BrdUrd treatment at 5 micrograms/ml for 6 days, PCA increased 6.8-fold in GOTO and 2.7-fold in SK-N-DZ with associated growth inhibition and morphological changes (I-type morphology converted to S-type in GOTO and N-type converted to an advanced N-type in SK-N-DZ). In contrast, only growth suppression was observed in 2 other cell lines, and no changes in PCA, growth or morphology were induced in the remaining 3 cell lines.

References

Sep 1, 1968·Proceedings of the National Academy of Sciences of the United States of America·G J GasicC C Stewart
Sep 1, 1970·Proceedings of the National Academy of Sciences of the United States of America·D Schubert, F Jacob

❮ Previous
Next ❯

Citations

Jul 1, 1991·Clinical & Experimental Metastasis·T YoshiharaS Imashuku
Aug 1, 1996·Cancer Genetics and Cytogenetics·H SonobeK Shimizu
Jan 1, 1991·Virchows Archiv. B, Cell Pathology Including Molecular Pathology·H SonobeT Goto
Aug 1, 1994·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·S ScheilK Unsicker
Jun 19, 1992·International Journal of Cancer. Journal International Du Cancer·T YoshiharaS Imashuku
May 11, 1999·Differentiation; Research in Biological Diversity·S McBrideM Clynes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.